Evidence map›Paper›PMID 21368652›Full record

ArticleAnesthesiology2011

5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice.

De-Yong Liang, XiangQi Li, J David Clark

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.International journal of environmental research and public health · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. KThe Journal of pharmacology and experimental therapeutics · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

De-Yong LiangDepartment of Anesthesiology, Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto, California 94304, USA. dyliang@stanford.edu
XiangQi Li
J David Clark
VA Palo Alto Health Care System · US

Funding

Genetic Determinants of Opioid-Induced HyperalgesiaR01DA021332 · NIDA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI CLARK, DAVID J. · 2007 to 2011
$1.2M
NIDA NIH HHS R01 DA021332PHS HHS R01 GMO79126
6 · The paper itself

Abstract

backgroundOpioid-induced hyperalgesia (OIH) and tolerance are challenging maladaptations associated with opioids in managing pain. Recent genetic studies and the existing literature suggest the 5-hydroxytryptamine type 3 (5-HT3) receptor participates in these phenomena. The location of the relevant receptor populations and the interactions between the 5-HT3 system and other systems controlling OIH and tolerance have not been explored, however. We hypothesized that 5-HT3 receptors modulate OIH and tolerance, and that this modulation involves the control of expression of multiple neurotransmitter and receptor systems.

methodsC57BL/6 mice were exposed to a standardized 4-day morphine administration protocol. The 5-HT3 antagonist ondansetron was administered either during or after the conclusion of morphine administration. Mechanical testing was used to quantify OIH, and thermal tail-flick responses were used to measure morphine tolerance. In other experiments spinal cord and dorsal root ganglion tissues were harvested for analysis of messenger RNA concentrations by real-time polymerase chain reaction or immunochemistry analysis.

resultsThe results showed that (1) systemic or intrathecal injection of ondansetron significantly prevented and reversed OIH, but not local intraplantar injection; (2) systemic or intrathecal injection of ondansetron prevented and reversed tolerance; and (3) ondansetron blocked morphine-induced increases of multiple genes relevant to OIH and tolerance in dorsal root ganglion and spinal cord.

conclusionsMorphine acts via a 5-HT3-dependent mechanism to support multiple maladaptations to the chronic administration of morphine. Furthermore, the use of 5-HT3 receptor antagonists may provide a new avenue to prevent or reverse OIH and tolerance associated with chronic opioid use.

Indexed as

Analgesics, OpioidAnimalsDrug ToleranceGanglia, SpinalHyperalgesiaMaleMiceMice, Inbred C57BLMorphineOndansetronReceptors, Serotonin, 5-HT3Reverse Transcriptase Polymerase Chain ReactionSerotonin AntagonistsAnalgesics, OpioidMorphineOndansetronReceptors, Serotonin, 5-HT3Serotonin Antagonists

Identifiers

PMID21368652
PMCPMC3085696
OpenAlexW1969537866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.